Tissue Engineering Market Research Report - Global forecast till 2022

Tissue Engineering Market Research Report - Global forecast till 2022

ID: MRFR/HC/1592-CRR | September, 2017 | Region: Global | 110 pages | Cooked Research Reports

Global Tissue Engineering Market Information: By Material (Biomimetic Materials, Nano-Fibrous Materials, Composite Materials, Nano-Composite Material), and By Applications (Orthopedics, Musculoskeletal and Spine, Skin/Integumentary, Cancer, Dental, Cardiology, Urology, Neurology, Cord Blood & Cell Banking, GI & Gynecology and others) - Forecast Till 2022

 


FIGURE 1 Global Tissue Engineering Market by Material, 2016 (%)

Global Tissue Engineering Market


Source: National Institute of Biomedical Imaging and Bioengineering, National Center for Biotechnology Information, Wiley Online Library, Department of Biotechnology, Directorate of Industries, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


 


Intended Audience



  • Tissue engineering manufacturers & suppliers

  • Biotechnology companies

  • Hospitals

  • Clinics

  • Academic research institutes

  • Government institutes

  • Market research and consulting service providers


 


Research Methodology

Global Tissue Engineering Market-


Source: OIE American Dental Association (ADA), National Academy of Medicine, American Student Dental Association (ASDA), FDI World Dental Federation, Utah Dental Association (UDA), World Health Organization, Directorate of Industries, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation 


 


Market Synopsis of the Global Tissue Engineering Market
Market Scenario
Tissue engineering is an interdisciplinary field, which combines the principles of engineering and life sciences toward the development of biological substitutes. These biological substitutes are used to replace or restore tissue or organ function. Tissue engineering and regenerative medicine deploys small molecules, biologics, cell-based therapies, and organ transplantation, etc. It involves the use of a scaffold for the formation of new tissue for a medical purpose


The global tissue engineering market is growing at a steady pace and is expected to grow at a CAGR of 17.22 % during review period 2017-2022. Due to increasing advancement in the healthcare technology, consistent supply of functional tissues, and advantage of tissue engineering methods such as it has replaced animal used for drug testing in pharmaceuticals, drive the growth of the market. Since the technique is cost-effective, it will boost the market growth.


On the other hand, shortage of organ donor in organ transplantation may hamper market growth over the assessment period.



Segments                                                                                                                                          
Tissue engineering market has been segmented on the basis of materials, which comprises of biomimetic materials, nano-fibrous materials, composite materials, and nano-composite material.


On the basis of applications, the market is segmented into orthopedics, musculoskeletal and spine, skin/integumentary, cancer, dental, cardiology, urology, neurology, cord blood & cell banking, GI & gynecology, and others.



Regional Analysis of the Global Tissue Engineering Market                
The Americas region accounted for a largest share of USD 7,100.1 million in 2016, owing to the well-developed infrastructure in the healthcare sector, high healthcare expenditure, and the presence of the leading players.


Europe is the second largest tissue engineering market, which holds a noticeable share of the global market. The European market is expected to grow significantly during the forecast period owing to well-developed healthcare and increasing investment in research and development in healthcare. Moreover government encouragement to life sciences industries will boost the market growth over the review period. Mainly Germany, the UK, and France contribute significantly to the growth of the European market.


In Asia Pacific, rising number of research & development institutes, increasing demand for better diagnostic and treatment methods, and cost-effective services in the drives the market growth.


The Middle East & Africa is expected to show steady growth in this market due to low technology penetration and less availability of innovative healthcare facilities.



Key Findings



  • The global tissue engineering market is expected to reach USD 48,017.5 million by 2022 at CAGR of 17.22%.

  • Nano-fibrous material segment on the basis of material holds the largest share to reach USD 13,279.2 million by 2022 from USD 4,155.8 million in 2016.

  • The Americas holds the largest share of tissue engineering market and is projected to reach USD 17,889.6 million by the end of the forecast period.

  • Asia Pacific is the fastest growing region across the globe and expected to grow at a CAGR of 15.24% during the forecast period.




 Key Players in the Global Tissue Engineering Market                                


Some of the key players in this market: Cook, Acelity, Baxter, DePuy Synthes Companies, Medtronic, Zimmer Inc., and Stryker


The report on the global tissue engineering market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions


 


 

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
Currency

TABLE OF CONTENTS

2.1 Introduction 13

2.2 Scope of Study 13

2.3 Research Objective 13

2.4 Assumptions & Limitations 14

2.4.1 Assumptions 14

2.4.2 Limitations 14

2.5 Market Structure 15

3.1 Research Process 16

3.2 Market Size Estimation 17

3.2.1 Market Share Analysis 18

3.3 Forecast Model 19

4.1 Drivers 20

4.1.1 Reliable Supply of functional tissues 20

4.1.2 Use of Tissue Engineering can replace the animal testing model 20

4.1.3 Approaching towards its cost-effectiveness 20

4.2 Barriers 21

4.2.1 Shortage of donor organ 21

4.2.2 Scaling up of a specific cell 21

4.3 Opportunity 21

4.3.1 Growing Geriatric Population Presents Significant Growth Opportunity 21

4.3.2 High demand of tissue engineering in cosmetic and reconstructive surgery 21

4.4 Mega Trends 22

4.5 Macroeconomic Indicators 22

5.1 Porter’s Five Forces Analysis 24

5.1.1 Threat from a New Entrant 24

5.1.2 Bargaining Power of Buyer 25

5.1.3 Bargaining Power of Supplier 25

5.1.4 Threat from substitute 26

5.1.5 Intensity of Competitive Rivalry 26

5.2 Supply Chain Analysis 26

5.2.1 Raw Material 27

5.2.2 Supplier 27

5.2.3 Manufacturer 28

5.2.4 Distributer 28

5.2.5 Customer-Retailer 29

5.2.6 Consumer 29

5.3 Pricing analysis 30

5.4 Investment Opportunity Analysis 31

5.4.1 Market size, growth rate, and profitability 31

5.4.2 Investment Risks 31

5.4.3 Market Outlook 31

5.4.4 Competitors 31

5.4.5 Projections 32

5.5 Merger and Acquisition Landscape 32

6.1 Introduction 33

6.2 Nano-fibrous Material 35

6.3 Biomimetic Material 35

6.4 Composite Material 36

6.5 Nano-composite Material 37

7.1 Introduction 39

7.2 Orthopedics, Musculoskeletal and Spine 41

7.3 Skin/Integumentary 42

7.4 Cancer 42

7.5 Dental 43

7.6 Cardiology 44

7.7 Urology 45

7.8 Neurology 45

7.9 Cord Blood & Cell Banking 46

7.10 GI & Gynaecology 47

7.11 Others (Organ Replacement, Transplants & ophthalmology) 48

8.1 Introduction 49

8.2 Americas 51

8.2.1 U.S. 54

8.2.2 Canada 56

8.2.3 South America 58

8.3 Europe 60

8.3.1 Germany 63

8.3.2 France 65

8.3.3 U.K. 67

8.3.4 Italy 69

8.3.5 Spain 71

8.3.6 Eastern Europe 73

8.4 Asia-Pacific 75

8.4.1 Japan 78

8.4.2 China 80

8.4.3 India 82

8.4.4 Australia 84

8.4.5 Republic of Korea 86

8.4.6 Rest of Asia-Pacific 88

8.5 Middle East & Africa 90

8.5.1 Middle East 93

8.5.2 Africa 95

9.1 Introduction 97

9.2 Company Share Analysis 98

10.1 Stryker 99

10.1.1 Company Overview 99

10.1.2 Financials 99

10.1.3 Products 99

10.1.4 Strategy 99

10.1.5 Key Developments 99

10.2 Zimmer Inc. 100

10.2.1 Company Overview 100

10.2.2 Financials 100

10.2.3 Products 100

10.2.4 Strategy 100

10.2.5 Key Developments 100

10.3 Medtronic 101

10.3.1 Company Overview 101

10.3.2 Financials 101

10.3.3 Products 101

10.3.4 Strategy 101

10.3.5 Key Developments 101

10.4 DePuy Synthes 102

10.4.1 Company Overview 102

10.4.2 Financials 102

10.4.3 Products 102

10.4.4 Strategy 102

10.4.5 Key Developments 102

10.5 Baxter 103

10.5.1 Company Overview 103

10.5.2 Financials 103

10.5.3 Products 103

10.5.4 Strategy 103

10.5.5 Key Developments 103

10.6 Acelity 104

10.6.1 Company Overview 104

10.6.2 Financials 104

10.6.3 Products 104

10.6.4 Strategy 104

10.6.5 Key Developments 104

10.7 Cook Medical 105

10.7.1 Company Overview 105

10.7.2 Financials 105

10.7.3 Products 105

10.7.4 Strategy 105

10.7.5 Key Developments 105

11.1 Key Findings 106

11.1.1 From CEO’s View Point 106

11.1.2 Unmet Needs 106

11.2 Key companies to watch 106

12.1 Discussion Blue Print 107

12.2 References 109